GlassScriptPhysician profile
Diana Roth
NPI 1477559086
$361.55
in general payments reported to CMS, 2019-2025
7 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.63 · 2021: $21.56 · 2023: $55.92 · 2024: $69.57 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $120.37 | 2021-2025 | Nexplanon, Jada System |
| Shield Therapeutics INC | $54.08 | 2023-2025 | Accrufer |
| Coopersurgical, INC. | $51.92 | 2025 | Paragard T 380a |
| Exact Sciences Corporation | $50.99 | 2024-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $43.71 | 2025 | Veozah |
| Sumitomo Pharma America, INC. | $20.85 | 2023 | Myfembree |
| Daiichi Sankyo INC. | $19.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.